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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S310proteoglycan content was found decreased by histomorphometry
(score decline -64%) and biochemical analysis of GAG (-75%) and total
collagen (-30%) content. Gene expression of catabolic enzymes
(MMP13, MMP1, MMP2), and genes involved in inﬂammatory response
(IL8, CCL2, CCL4 CXCL2) was signiﬁcantly increased (>4-fold) and genes
related to ECM formation (COL2A1, COMP, Aggrecan, COL8A1, COL11A1)
were decreased (<-4-fold). Whereas histological and biochemical
characteristics of the TNF-alpha induced model match with observa-
tions known from human OA cartilage, gene expression analysis
revealed contrary gene expression pattern related to ECM formation
(COL2A1, COL11A1, COMP) and to hypertrophic bone formation
(COL10A1). The addition of TGF-b1 and PRP during TNF-alpha stimu-
lation led to reduced GAG loss (both 40%) whereas IL1b enhanced the
GAG loss by further 10% demonstrating responsiveness of the model to
test substances.
Conclusions: The use of porcine chondrocytes in micromasses and the
addition of TNF-alpha resulted in the induction of some typical features
of OA such as extensive ECM loss and induction of genes related to
catabolic activity and inﬂammatory response. In contrast to human OA,
ECM formation was inhibited, which might be a consequence of the
exclusive use of TNF-alpha, which is only one of many impacting factors
in OA. Although not all characteristics of human OA could be demon-
strated, the presented test system was suitable to detect effects of test
substances. TNF-alpha induced porcine micromasses can be a useful
supplement to existing preclinical tests in OA and an alternative to the
use of human tissue in vitro.
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Purpose: To study the chondrogenic differentiation of human bone
marrow mesenchymal stem cells (hBM-MSCs) grown on different
collagen scaffolds and evaluate the resulting cartilage-like constructs.
Methods: hBM-MSCs were isolated, characterized and tested for their
multipotential capacity. hBM-MSCs were cultured on different collagen
scaffolds for 30 days in a chondrogenic differentiation medium. We
tested four scaffolds: Col I + Col II (C1C2); Col I + Col II + heparan
sulphate (C1C2HS); Col I + Col II +chondroitin sulfate (C1C2CHS); Col I +
heparin (C1OLH3). Chondrogenic differentiation was conﬁrmed by
histochemical and immunohistochemical analysis. Relative gene
expression of characteristic chondrocyte genes, SOX9 ([Sex determining
region Y]-box 9), COL II (Collagen type II, alpha 1), AGG (Aggrecan), was
performed. Furthermore, collagen assays were used to measure
collagen concentration in culture supernatants. Transmission and
scanning electronic microscopy were performed to study the cell
ultrastructure and cell morphology.
Results: hBM-MSCs were able to grow in the surface but also inside the
different types of collagen supports. The percentage of cells, regarding
the area of the analyzed support, was higher than 75% in the C1C2HS
and in the C1C2CHS, and higher than 50% in the other scaffolds tested.
Moreover, proliferation was observed by PCNA (Proliferating cell
nuclear antigen) immunostaining in all the scaffolds studied. hBM-
MSCs showed the formation of cell aggregates. Extracellular matrix of
the cells grown on all the scaffolds showed abundant proteoglycans
(Figure, A). Cells showed positive immunostaining for type II collagen in
C1C2 (Figure, A). The extracellular matrix showed positive immuno-
staining for type II collagen in C1C2HS and C1C2CHS (Figure, A).
Expression gene of COL II was also detected, along with SOX9 in all the
constructs, proving that there was an early chondrogenesis (Figure, B).
Moreover, expression of AGGwas detected in all scaffolds, but C1C2 and
C1C2HS showed the higher relative expression (Figure, B). Cells pre-
sented characteristics similar to chondrocytes, as it was shown by
scanning electron microscopy, with semispherical shape and anchors
(Figure, C). Also, it was seen extracellular matrix around the cells and
a huge amount of secretion vesicles (Figure, C). Transmission electron
microscopy showed a high secretory activity and a high amount of
mitochondrias in all cells, except in cells of C1OLH3 (Figure, C).Furthermore, we only observed extracellular matrix on C1C2CHS, pre-
senting a large organization of collagen ﬁbrils (Figure, C). The highest
total collagen concentration was detected in culture supernatants
between 11 to 21 days, showing the beginning of the differentiation.
Conclusions: Our data demonstrated that these different collagen
scaffolds were optimal for hBM-MSCs growth. hBM-MSCs cultured in
chondrogenic medium on C1C2HS and C1C2CHS scaffolds were able to
differentiate into chondrocyte-like cells and to synthesize cartilage-like
extracellular matrix. These two scaffolds are suitable candidates for
chondrogenic differentiation of hBM-MSCs, and they may be used to
construct cartilage-like tissue in vitro. Acknowledgements: B. Parma
(OPOCRIN S.P.A.); CAM (S2009/MAT-1472); CIBER BBN CB06-01-0040;
REDICENT; SAI-UDC.
Figure. A) Images obtained from the different constructs (in columns) by Safranin-
O staining and Col II immunostaining. B) On the left, it is represented/the relative
expression levels, in all the constructs, of characteristic chondrogenic genes. On
the right, it is represented the collagen concentration on the supernatant, along
the 30 days of differentiation. C) Images obtained from the different constructs (in
columns) by transmission electron microscopy (TEM) and scanning electron
microscopy (SEM).
602
TISSUE ENGINEERING FOR CARTILAGE REPAIR: GROWTH AND
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Purpose: To evaluate the proliferation and chondrogenic potential of
human Bone Marrow Mesenchymal Stem Cells (hBM-MSCs) grown on
type I Collagen (Col I) and different concentrations of Heparan Sulfate
(HS) scaffolds. We also studied the quality of the neo-synthesized
cartilaginous tissue.
Methods: hBM-MSCs were cultured over the scaffolds in chondrogenic
differentiation medium (Lonza, Biowhittaker, Belgium) or DMEM with
20% FBS (Fetal Bovine Serum) for 15 and 30 days, in both cases plus 100
nM PTHrP (Parathyroid hormone-related protein). Scaffolds without
cells were cultured in chondrogenic medium as negative controls.
Chondrogenic differentiation and neosythesized cartilage quality were
evaluated by histochemical and immunohistochemical analysis,
Figure 1. Histochemical (1A-1C) and Immunohistochemical (1D-1F) stainings;
Chondrogenic genes expression of MSCs-hBM cultured in DMEM and Chondron-
genic medium, measured as Relative Expression Levels (R.E.L.) (2A-2C); SEM (3A-
3D) and TEM (3E-3H) images; Total collagen concentration (mg/ 650 ml) measured in
the culture supernatants, supernatants of chondrogenic (4A) and DMEM medium
(4B).
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natants were collected every 3-4 days to determine collagen presence
by Elisa assays.
Results: Hematoxylin-eosin (HE) (ﬁg.1A) and Masson’s trichrome (MT)
(ﬁg.1B) staining showed that stimulated hBM-MSCs spread throughout
the biomaterials in high percentage, showing a good morphology at
both times of study as well as awide distribution of Extracellular Matrix
(ECM). These constructs showed positivity for safranin O (SO) (ﬁg.1C),
Toluidine Blue (TB), aggrecan (Agg) (ﬁg.1D) and type II collagen (Col II)
(ﬁg.1E). Isolated cells were able to proliferate on Col I and various
concentrations of HS scaffolds, as they showed high percentages of
positivity for Proliferating Cell Nuclear Antigen (PCNA) proliferation
marker (ﬁg.1F). hBM-MSCs proliferated better when cultured in chon-
drogenic medium than in the usual growth medium (DMEM 20%
FBS).Degradation of biomaterials was gradual, as ﬁbers were replaced
with ECM. Molecular analysis indicated the expression of cartilage-
characteristic genes, such as Sox9 [SRY (sex determining region Y)-box
9], Agg and Col II (ﬁg.2) and absence of Col I, a marker of hypertrophic
cells. Scanning and transmission electron microscopy conﬁrmed the
presence of cells and ECM after 15 and 30 days of culture. Cells attached
to the scaffolds and exhibited a rounded morphology (ﬁg.3A-3D). They
showed a high number of distended Rough Endoplasmic Reticulum
(R.E.R) cisternae (ﬁg.3E), electrodense and bright vesicles (ﬁg.3F, 3G),
and great amount of mitochondria, suggesting great cell activity. New
ﬁbrils were differentiated surrounding cell surfaces at both times of
study, conforming neosynthesized cartilage (ﬁg.3H). Finally, culture
supernatants analyses showed the release of collagen in most of thetime periods studied (ﬁg.4), conﬁrming the chondrogenic differentia-
tion of the hBM-MSCs.
Conclusions: Col I and HS scaffolds were optimal for hBM-MSCs growth
and also contributed to their phenotype maintenance. Our supports
favour differentiation towards chondrocytes-like cells after both 15 and
30 days in chondrogenic medium. Detection of extracellular matrix
characteristic compounds in the constructs conﬁrms chondrogenic
differentiation and synthesis of cartilaginous tissue, proving their
possible use to regenerate cartilage damages. Acknowledgements: B.
Parma (OPOCRIN S.P.A.); P. Esbrit (Fundación Jiménez Díaz),
CAM(S2009/MAT-1472); CIBER BBN CB06-01-0040; REDICENT.
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Purpose: Osteoarthritis is a degenerative disease characterized by the
degradation of articular cartilage. Human bone marrow mesenchymal
stem cells (BM-MSCs) have been presented as candidate cells for
cartilage repair due to their ability to undergo chondrogenic differen-
tiation after extensive expansion in vitro and stimulation with various
biomaterials in three-dimensional systems. Due to the attractive
properties of poly(L-lactic acid) (PLLA) and chitosan (CHT) scaffolds for
TE, this study is aimed at analyzing the chondrogenic potential of BM-
MSCs derived from OA patients, in PLLA, alone or combined with CHT,
for application in cartilage repair strategies.
Methods: PLLA scaffolds were prepared by a mixed technique of phase
separation and porogen; PLLA-CHT1 and-CHT2 were prepared by ﬁlling
PLLA with a CHT solution (0.5% w/v). For PLLA-CHT1: excess CHT was
removed and scaffolds were quenched in liquid nitrogen; For PLLA-
CHT2: CHT coating was dried at 37o C, for 24h; this was repeated three
times. Then, in both samples, CHT was gelled at -20o C, in a sodium
hydroxide-ethanol solution, during 3 days. Subsequently, samples were
washed in distilled water and freeze-dried. The morphology and
mechanical properties of the scaffolds were analyzed. BM-MSCs,Ă
